# The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023, Regulation 24: Amendment of Schedule 1 (fees for clinical investigations)


(1) Schedule 1 is amended as follows.
(2) For the heading to Table 1 substitute—
“Clinical investigation of a class I device, class IIa device or class IIb device, which is neither an implantable device nor a long-term invasive device.”.
(3) In the second column (Fee) in Table 1 (Clinical investigation of a class I device, class IIa device or non-invasive class IIb device)—
(a) in entry 1, for “£3,820” substitute “£7,472”, and
(b) in entry 2, for “£2,920” substitute “£5,711”.
(4) For the heading to Table 2 substitute—
“Clinical investigation of a class IIb device, which is either an implantable device or a long-term invasive device, or a class III device.”.
(5) In the second column (Fee) in Table 2 (Clinical investigation of an invasive class IIb device or class III device)—
(a) in entry 1, for “£5,040” substitute “£15,627”, and
(b) in entry 2, for “£3,570” substitute “£11,069”.

---
Source: https://www.legislation.gov.uk/ukdsi/2023/9780348244502/regulation/24 (the official version)
Page: https://openlegislation.uk/draft-medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2023/regulation-24
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

